Skip to main content

Lymphoscintigraphy

  • Chapter
  • First Online:
The Pathophysiologic Basis of Nuclear Medicine

Abstract

Lymphoscintigraphy has recently acquired an expanding role in clinical medicine. Most evaluations of lymphedema have assessed the lower extremities, but the upper extremities have also been studied, especially in patients with breast cancer who develop lymphedema following axillary dissection. Over the past three decades, in addition to its increasing utilization in the evaluation of lymphedema, it has been used to determine metastatic drainage sites in breast cancer, melanoma, and other cancer patients. In breast cancer patients, lymphoscintigraphy was originally used to detect tumor metastases to the axillary and internal mammary lymph node chains. Later, it was applied to the localization of lymph nodes for radiation therapy planning and for determining the completeness of surgical adenectomies. Currently, it is used mainly to determine the location of sentinel lymph node(s).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. McCance KL (1998) Pathophysiology, biological basis of disease in adults and children. Mosby, St. Louis, pp 968–1023

    Google Scholar 

  2. Guyton AC, Hall JE (1966) Textbook of medical physiology, 9th edn. Saunders, Philadelphia, pp 193–197

    Google Scholar 

  3. Weissleder R, Thrall JH (1989) The lymphatic system: diagnostic imaging studies. Radiology 172:315–317

    Article  CAS  PubMed  Google Scholar 

  4. Weiss L (1988) Cell and tissue biology, 6th edn. Urban and Schwarzenberg, Baltimore, pp 499–514

    Google Scholar 

  5. Ruggiero R, Muz J, Fietsam R Jr (1993) Reestablishment of lymphatic drainage after canine lung transplantation. J Thorac Cardiovasc Surg 106:167–171

    CAS  PubMed  Google Scholar 

  6. Ruggiero R, Fietsam R Jr, Thomas GA (1994) Detection of canine allograft lung rejection by pulmonary lymphoscintigraphy. J Thorac Cardiovasc Surg 108:253

    CAS  PubMed  Google Scholar 

  7. Clodius L (1990) Lymphedema. In: McCarthy JG (ed) Plastic surgery. Saunders, Philadelphia, pp 4093–4120

    Google Scholar 

  8. Peyton JW, Crosbie J, Bell TK (1981) High colloidal uptake in axillary nodes with metastatic disease. Br J Surg 68:507–509

    Article  CAS  PubMed  Google Scholar 

  9. Strand SE, Bergqvist L (1989) Radiolabeled colloids and macromolecules in the lymphatic system. Crit Rev Ther Drug Carrier Syst 6:211–238

    CAS  PubMed  Google Scholar 

  10. Szuba A, Shin WS, Strauss HW, Rockson S (2003) The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med 44:43–57

    PubMed  Google Scholar 

  11. Weissleder H, Weissleder R (1988) Lymphedema: evaluation of qualitative and quantitative lymphoscintigraphy in 238 patients. Radiology 167:729–735

    Article  CAS  PubMed  Google Scholar 

  12. Nawaz MK, Hamad MM, Abdel-Dayem HM (1990) Tc-99m human serum albumin lymphoscintigraphy in lymphedema of the lower extremities. Clin Nucl Med 15:794–799

    Article  CAS  PubMed  Google Scholar 

  13. Bergqvist L, Strand SE, Hafstrom L (1984) Lymphoscintigraphy in patients with malignant melanoma: a quantitative and qualitative evaluation of its usefulness. Eur J Nucl Med 9:129–135

    Article  CAS  PubMed  Google Scholar 

  14. Mavi A, Lakhani P, Zhuang H, Gupta NC, Alavi A (2005) Fluorodeoxyglucose-PET in characterizing solitary pulmonary nodules, assessing pleural diseases and the initial staging, restaging, therapy planning, and monitoring response of lung cancer. Radiol Clin North Am 43(1):1–24

    Article  PubMed  Google Scholar 

  15. Cabanas R (1977) An approach for the treatment of penile carcinoma. Cancer 39:456–466

    Article  CAS  PubMed  Google Scholar 

  16. Baas PC, Schraffordt KH, Hoekstra HJ, Van Bruggen JJ, Van der Weele LT, Oldhoff J (1992) Groin dissection in the treatment of lower-extremity melanoma. Short term and long term morbidity. Arch Surg 127:281–286

    Article  CAS  PubMed  Google Scholar 

  17. Morton DL, Wen DR, Wong JH (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392–399

    Article  CAS  PubMed  Google Scholar 

  18. Alex JC, Weaver DL, Fairbank JT (1993) Gamma-probe-guided lymph node localization in malignant melanoma. Surg Oncol 2:303–308

    Article  CAS  PubMed  Google Scholar 

  19. Thompson JF, Uren RF, Scolyer RA, Stretch JR (2005) Selective sentinel lymphadenectomy: progress to date and prospects for the future. Cancer Res 126:269–287

    Google Scholar 

  20. Guenther JM, Krishnamoorthy M, Tan LR (1997) Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 3:336–340

    CAS  PubMed  Google Scholar 

  21. McMasters KM, Giuliano AE, Ross MI, Reintgen DS, Hunt KK, Byrd DR et al (1998) Sentinel-lymph-node biopsy for breast cancer – not yet the standard of care. N Engl J Med 339:990–995

    Article  CAS  PubMed  Google Scholar 

  22. Strand SE, Persson BR (1979) Quantitative lymphoscintigraphy I: basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits. J Nucl Med 20:1038–1046

    CAS  PubMed  Google Scholar 

  23. Vendrell-Torne E, Setoain-Quinquer J, Domenech-Torne FM (1972) Study of normal mammary lymphatic drainage using radioactive isotopes. J Nucl Med 13:801–805

    CAS  PubMed  Google Scholar 

  24. Donegan WL, Spratt JS (1995) Cancer of the breast, 4th edn. Saunders, Philadelphia

    Google Scholar 

  25. Glass EC, Essner R, Giuliana AE (1999) Sentinel node localization in breast cancer. Semin Nucl Med 24:57–68

    Article  Google Scholar 

  26. Krasnow AZ, Hellman RS (1999) Lymphoscintigraphy revisited: 1999. In: Freeman LM (ed) Nuclear medicine annual. Mosby, St. Louis, pp 17–97

    Google Scholar 

  27. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen DS (1966) Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:1818–1822

    Article  Google Scholar 

  28. Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel-lymph-node resection compared with conventional axillary lymph node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomized phase 3 trial. Lancet Oncol 11:927–933

    Article  PubMed Central  PubMed  Google Scholar 

  29. Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569–575

    Article  CAS  PubMed  Google Scholar 

  30. Martínez-Rodríguez I, De Arcocha Torres M, Banzo I, Quirce R, Jiménez-Bonilla J, Medina-Quiroz P et al (2013) Evaluation of the contribution of the dynamic phase of lymphoscintigraphy to the detection of sentinel lymph node in breast cancer. Q J Nucl Med Mol Imaging 57:296–300.

    Google Scholar 

  31. van der Ploeg IM, Valdés Olmos RA, Kroon BB, Nieweg OE (2008) The hybrid SPECT/CT as an additional lymphatic mapping tool in patients with breast cancer. World J Surg 32:1930–1934

    Article  PubMed Central  PubMed  Google Scholar 

  32. Lerman H, Metser U, Lievshitz G, Sperber F, Shneebaum S, Even-Sapir E (2006) Lymphoscintigraphic sentinel node identification in patients with breast cancer: the role of SPECT-CT. Eur J Nucl Med Mol Imaging 33:329–337

    Article  CAS  PubMed  Google Scholar 

  33. Xing Y, Foy M, Cox DD, Kuerer HM, Hunt KK, Cormier JN (2006) Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 93:539–546

    Article  CAS  PubMed  Google Scholar 

  34. Hidar S, Bibi M, Gharbi O et al (2009) Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer. Int J Surg 7:272–275

    Article  PubMed  Google Scholar 

  35. Giuliano A, McCall L, Beitsch P et al (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases. The American College of Surgeons Oncology Z0011 Randomized Trial. Ann Surg 252:426–433

    PubMed  Google Scholar 

  36. Balch CM, Reintgen DS, Kirkwood JM, Houghton A, Peters L, Ang KK (1997) Cutaneous melanoma. In: Devita VT (ed) Cancer: principles and practice of oncology, 5th edn. Lippincott-Raven, Philadelphia, pp 1947–1994

    Google Scholar 

  37. Halpern AC, Shuchter LM (1997) Prognostic models in melanoma. Semin Oncol 24(Suppl 4):S2–S7

    CAS  PubMed  Google Scholar 

  38. Homsi J, Kashani-Sabet M, Messina JL, Daud A (2005) Cutaneous melanoma: prognostic factors. Cancer Control 12(4):223–229

    PubMed  Google Scholar 

  39. Shivers SC, Wang X, Li W, Joseph E, Messina J, Glass LF, DeConti R, Cruse CW, Berman C, Fenske NA, Lyman GH, Reintgen DS (1998) Molecular staging of malignant melanoma. JAMA 280:1410–1415

    Article  CAS  PubMed  Google Scholar 

  40. Godellas CV, Berman CG, Lyman G (1995) The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases. Am Surg 61:97–101

    CAS  PubMed  Google Scholar 

  41. Johnson TM, Bradford CR, Gruber SB, Sondak VK, Schwartz JL (2004) Staging workup, sentinel node biopsy, and follow-up tests for melanoma: update of current concepts. Arch Dermatol 140(1):107–113

    Article  PubMed  Google Scholar 

  42. Alex JC, Krag DN, Harlow SP (1998) Localization of regional lymph nodes in melanomas of the head and neck. Arch Otolaryngol Head Neck Surg 124:135–140

    Article  CAS  PubMed  Google Scholar 

  43. Balch CM, Soong SJ, Gershenwald JE et al (2001) Prognostic factors analysis of 17, 600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19:3622–3634

    CAS  PubMed  Google Scholar 

  44. Wells KE, Cruse CW, Daniels S (1994) The use of lymphoscintigraphy in melanoma of the head and neck. Plast Reconstr Surg 93:757–761

    Article  CAS  PubMed  Google Scholar 

  45. Berman CG, Norman J, Cruse CW (1992) Lymphoscintigraphy in malignant melanoma. Ann Plast Surg 28:29–32

    Article  CAS  PubMed  Google Scholar 

  46. Jonk A, Kroon BB, Mooi WJ (1989) Contralateral inguinal lymph node metastasis in patients with melanoma of the lower extremities. Br J Surg 76(11):1161–1162

    Article  CAS  PubMed  Google Scholar 

  47. Cole DJ, Baron PL (1996) Surgical management of patients with intermediate thickness melanoma: current role of elective lymph node dissection. Semin Oncol 23:719–724

    CAS  PubMed  Google Scholar 

  48. Yeung H, Yeh S, Colt D, El-Shirbiny A, Brady M, Lewis J, Larson SM (1996) Lymphoscintigraphy with sulphur colloid for identification of sentinel node in malignant melanoma. J Nucl Med 37:138P (abstract)

    Google Scholar 

  49. Xiong L, Engel H, Gazyakan E, et al (2014) Current techniques for lymphatic imaging: State of the art and future perspectives. Eur J Surg Oncol 40:270–276

    Google Scholar 

  50. Mudun A, Murray DR, Herda SC (1996) Early-stage melanoma: lymphoscintigraphy, reproducibility of sentinel node detection, and effectiveness of the intraoperative gamma probe. Radiology 199:171–175

    Article  CAS  PubMed  Google Scholar 

  51. Tonakie A, Yahanda A, Sondak V, Wahl RL (1998) Reproducibility of lymphoscintigraphy drainage patterns in sequential Tc-99m HSA and Tc-99m sulfur colloid studies: implications for sentinel node identification in melanoma. J Nucl Med 39:25P (abstract)

    Google Scholar 

  52. Klode J, Poeppel T, Boy C, Mueller S, Schadendorf D, Körber A, Stoffels I, Dissemond J (2011) Advantages of preoperative hybrid SPECT/CT in detection of sentinel lymph nodes in cutaneous head and neck malignancies. J Eur Acad Dermatol Venereol 25:1213–1221

    Article  CAS  PubMed  Google Scholar 

  53. Kretschmer L, Altenvoerde G, Meller J, Zutt M, Funke M, Neumann C, Becker W (2003) Dynamic lymphoscintigraphy and image fusion of SPECT and pelvic CT-scans allow mapping of aberrant pelvic sentinel lymph nodes in malignant melanoma. Eur J Cancer 39:175–183

    Article  CAS  PubMed  Google Scholar 

  54. Kroon BK, Horenblas S, Estourgie SH et al (2004) How to avoid false-negative dynamic sentinel node procedures in penile carcinoma. J Urol 171:2191–2194

    Article  CAS  PubMed  Google Scholar 

  55. Kroon BK, Horenblas S, Lont AP, Tanis PJ, Gallee MP, Nieweg OE (2005) Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases. J Urol 173:816–819

    Article  CAS  PubMed  Google Scholar 

  56. Wespes E, Simon J, Schulman CC (1986) Cabanas approach: is sentinel node biopsy reliable for staging penile carcinoma? Urology 28:278–279

    Article  CAS  PubMed  Google Scholar 

  57. Leijte JA, Kroon BK, Valdes Olmos RA, Nieweg OE, Horenblas S (2007) Reliability and safety of current dynamic sentinel node biopsy for penile carcinoma. Eur Urol 52:170–177

    Article  PubMed  Google Scholar 

  58. Pettaway CA, Jularbal FA, Babaian RJ, Dinney CPN, Pisters LL (1999) Intraoperative lymphatic mapping to detect inguinal metastases in penile carcinoma: results of a pilot study. J Urol 161:159

    Article  Google Scholar 

  59. Algaba F, Horenblas S, Solsona E, Tana S, Van Der Poel H, Watkin NA (2010) EAU penile cancer guidelines 2009. Eur Urol 57:1002–1012

    Article  PubMed  Google Scholar 

  60. Heidenreich A, Varga Z, Von Knobloch R (2002) Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 167(4):1681–1686

    Article  PubMed  Google Scholar 

  61. Wawroschek F, Vogt H, Weckermann D, Wagner T, Harzmann R (1999) The sentinel lymph node concept in prostate cancer – first results of gamma probe-guided sentinel lymph node identification. Eur Urol 36:595–600

    Article  CAS  PubMed  Google Scholar 

  62. Holl G, Dorn R, Wengenmair H, Weckermann D, Sciuk J (2009) Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2,000 patients. Eur J Nucl Med Mol Imaging 36:1377–1382

    Article  CAS  PubMed  Google Scholar 

  63. Kizu H, Takayama T, Fukuda M, Egawa M, Tsushima H, Yamada M, Ichiyanagi K, Yokoyama K, Onoguchi M, Tonami N (2005) Fusion of SPECT and multidetector CT images for accurate localization of pelvic sentinel lymph nodes in prostate cancer patients. J Nucl Med Technol 33:78–82

    PubMed  Google Scholar 

  64. Vermeeren L, Valdés Olmos RA, Meinhardt W, Bex A, van der Poel HG, Vogel WV, Sivro F, Hoefnagel CA, Horenblas S (2009) Value of SPECT/CT for detection and anatomic localization of sentinel lymph nodes before laparoscopic sentinel node lymphadenectomy in prostate carcinoma. J Nucl Med 50:865–870

    Article  PubMed  Google Scholar 

  65. Koo GS, Lim YC, Lee JS, et al (2006) Management of contralateral N0 neck in oral cavity squamous cell carcinoma. Head Neck 28:896–901

    Google Scholar 

  66. Hosal AS, Carrau RL, Johnson JT, Myers EN (2000) Selective neck dissection in the management of the clinically node-negative neck. Laryngoscope 110:2037–2040

    Article  CAS  PubMed  Google Scholar 

  67. Terui S, Terauchi T, Ebihara S et al (1992) Lymphoscintigraphy of head and neck cancer. Angiology 43:925–932

    Article  CAS  PubMed  Google Scholar 

  68. Koch WM, Choti MA, Civelek AC et al (1998) Gamma probe-directed biopsy of the sentinel node in oral squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 124:455–459

    Article  CAS  PubMed  Google Scholar 

  69. Pitman KT, Johnson JT, Edington H et al (1998) Lymphatic mapping with isosulfan blue dye in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 124:790–793

    Article  CAS  PubMed  Google Scholar 

  70. Shoaib T, Soutar DS, Prosser JE et al (1999) A suggested method for sentinel node biopsy in squamous cell carcinoma of the head and neck. Head Neck 21:728–733

    Article  CAS  PubMed  Google Scholar 

  71. Kosuda S, Kusano S, Kohno N, Ohno Y, Tanabe T, Kitahara S, Tamai S (2003) Feasibility and cost-effectiveness of sentinel lymph node radiolocalization in stage N0 head and neck cancer. Arch Otolaryngol Head Neck Surg 129(10):1105–1109

    Article  PubMed  Google Scholar 

  72. Nieuwenhuis EJ, Colnot DR, Pijpers HJ, Castelijns JA, van Diest PJ, Brakenhoff RH, Snow GB, van den Brekel MW (2000) Lymphoscintigraphy and ultrasound-guided fine needle aspiration cytology of sentinel lymph nodes in head and neck cancer patients. Recent Results Cancer Res 157:206–217

    Article  CAS  PubMed  Google Scholar 

  73. Freire AR, Lima EN, Almeida OP, Kowalski LP (2003) Computed tomography and lymphoscintigraphy to identify lymph node metastases and lymphatic drainage pathways in oral and oropharyngeal squamous cell carcinomas. Eur Arch Otorhinolaryngol 260(3):148–152

    PubMed  Google Scholar 

  74. Paleri V, Rees G, Arullendran P et al (2005) Sentinel node biopsy in squamous cell cancer of the oral cavity and oral pharynx: a diagnostic meta-analysis. Head Neck 27:739–747

    Article  PubMed  Google Scholar 

  75. Civantos FJ, Zitsch RP, Schuller DE, Agrawal A, Smith RB et al (2010) Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial. Clin Oncol 28:1395–1400

    Article  Google Scholar 

  76. Joosten JJ, Strobbe LJ, Wauters CA, Pruszczynski M, Wobbes T, Ruers TJ (1999) Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 86:482–486

    Article  CAS  PubMed  Google Scholar 

  77. Cserni G, Vajda K, Tarjan M, Bori R, Svebis M, Baltas B (1999) Nodal staging of colorectal carcinomas from quantitative and qualitative aspects. Can lymphatic mapping help staging? Pathol Oncol Res 5:291–296

    Article  CAS  PubMed  Google Scholar 

  78. Bertagnoll MI, Miedema B, Redston M, Dowell J, Niedzwiecki D, Fleshman J, Bem J, Mayer R, Zinner M, Compton C (2004) Sentinel node staging of resectable colon cancer results of a multicenter study. Ann Surg 240:624–630

    Google Scholar 

  79. Wiese DA, Saha S, Badin J (1999) Sentinel lymph node mapping in staging of colorectal carcinoma. Am J Clin Pathol 112:542

    Google Scholar 

  80. Saha S, Wiese D, Badin J, Beutler T, Nora D, Ganatra BK et al (2000) Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann Surg Oncol 7:120–124

    Article  CAS  PubMed  Google Scholar 

  81. Dahl K, Westlin J, Kraaz W, Winqvist O, Bergkvist L, Thorn M (2005) Identification of sentinel nodes in patients with colon cancer. Eur J Surg Oncol 31(4):381–385

    Article  CAS  PubMed  Google Scholar 

  82. Paramo JC, Summerall J, Poopiti R, Mesko TW (2002) Validation of sentinel node mapping with colon cancer. Ann Surg Oncol 9(6):550–554

    Article  PubMed  Google Scholar 

  83. Bembenek A, Schneider U, Gretschel S, Fischer J, Schlag PM (2005) Detection of lymph node micrometastases and isolated tumor cells in sentinel and nonsentinel lymph nodes of colon cancer patients. World J Surg 29:1172–1175

    Article  PubMed  Google Scholar 

  84. Kitagawa Y, Watanabe M, Hasegawa H, Yamamoto S, Fujii H, Yamamoto K, Matsuda J, Mukai M, Kubo A, Kitajima M (2002) Sentinel node mapping for colorectal cancer with radioactive tracer. Dis Colon Rectum 45(11):1476–1480

    Article  PubMed  Google Scholar 

  85. Trocha SD, Nora DT, Saha SS, Morton DL, Wiese D, Bilchik AJ (2003) Combination probe and dye-directed lymphatic mapping detects micrometastases in early colorectal cancer. J Gastrointest Surg 7(3):340–346

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Abdelhamid H. Elgazzar MD, FCAP .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Krasnow, A.Z., Elgazzar, A.H., Kazem, N., Alenezi, S.A. (2015). Lymphoscintigraphy. In: Elgazzar, A. (eds) The Pathophysiologic Basis of Nuclear Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-06112-2_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-06112-2_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-06111-5

  • Online ISBN: 978-3-319-06112-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics